SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH M impact

AbbVie, Disco Pharmaceuticals Enter Solid Tumor Collaboration

AbbVie and Disco Pharmaceuticals have formed a collaboration involving an option-to-license deal.

ABBV

Related stories